Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiestrogen vs Aromatase Inhibitor After Chemotherapy for Adjuvant Setting: Efficacy of Endocrine Therapy After Chemotherapy in Postoperative Adjuvant Therapy for Breast Cancer

NCT00437359 is registered in ClinicalTrials.gov with Japan Breast Cancer Research Network as lead sponsor.

NCT NCT00437359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00437359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiestrogen vs Aromatase Inhibitor After Chemotherapy for Adjuvant Setting: Efficacy of Endocrine Therapy After Chemotherapy in Postoperative Adjuvant Therapy for Breast Cancer
Lead sponsor
Japan Breast Cancer Research Network
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2007
Completion date
May 31, 2020
Enrollment
240 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms